http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101931224-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101931224-B1 |
| titleOfInvention | Substituted pyrazolopyrimidines as glucocerebrosidase activators |
| abstract | The present invention provides substituted pyrazolopyrimidines and dihydropyrazolopyrimidines, and related compounds, as useful chaperones of glucocerebrosidase. The compounds of the present invention are potent and selective activators of glucocerebrosidase. These compounds are useful in treating the herpes disease and preventing the symptoms of hypercoagulases present in people with the GBA mutation gene. |
| priorityDate | 2010-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 429.